MARKET

EVOK

EVOK

Evoke Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.080
+0.020
+1.89%
Closed 16:00 04/08 EDT
OPEN
1.040
PREV CLOSE
1.060
HIGH
1.130
LOW
1.040
VOLUME
72.67K
TURNOVER
--
52 WEEK HIGH
1.790
52 WEEK LOW
0.5001
MARKET CAP
26.39M
P/E (TTM)
-3.2817
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EVOK stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.

EPS

EVOK News

More
  • Evoke Pharma EPS misses by $0.01
  • seekingalpha · 03/12 17:41
  • Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results
  • GlobeNewswire · 03/12 13:30
  • Evoke Pharma Q4 EPS $(0.06) Up From $(0.1) YoY
  • Benzinga · 03/12 12:42
  • Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™
  • GlobeNewswire · 01/27 13:30

Industry

Pharmaceuticals
+2.78%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About EVOK

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
More

Webull offers kinds of Evoke Pharma Inc stock information, including NASDAQ:EVOK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVOK stock news, and many more online research tools to help you make informed decisions.